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714Calf muscle stimulation with the Veinoplus device
results in a signiﬁcant increase in lower limb inﬂow
without generating limb ischemia or pain in patients
with peripheral artery disease
Pierre Abraham, MD, PhD,a,b Victor Mateus, MD,b Francois Bieuzen, PhD,c Naﬁ Ouedraogo, MD,b
Fallou Cisse, MD, PhD,d andGeorges Leftheriotis, MD, PhD,a,b Angers and Paris, France; and Dakar, Sénégal
Objective: Increase in arterial inﬂow to the lower limbs is important to obtain functional improvement in peripheral artery
disease (PAD) patients with claudication. The aim of this study was to assess the effect of electrical stimulation of calf
muscles on arterial inﬂow and tissue oxygen content in PAD in the area of stimulation.
Methods: Fifteen adult patients [mean (standarddeviation) age, 62 (12 ) years; height, 165 (8) cm;weight, 76 (13) kg; lowest
ankle-brachial index 0.66 (0.19)]with stable arterial claudicationwere recruited.All patients performeda treadmill test (3.2
km/h, 10% slope) associatedwith a transcutaneous oximetry test expressed as decrease fromrest of oxygenpressure (DROP)
index values (calf changes minus chest changes from rest) with a maximum walking distance (median [25th/75th percen-
tiles]) of 295 [133-881] m. The DROP index on the symptomatic side wase25 [L18/L34] mmHg. On another day the
patients underwent electrical stimulation in the seated position on the leg that was the most symptomatic on the treadmill.
After resting values were recorded, the gastrocnemius was stimulated for 20 minutes at increasing contraction rates at 5-
minute steps of 60, 75, 86, and 100 bpm on the most symptomatic side. Arterial blood inﬂow with duplex Doppler ultra-
sound scanningof the femoral artery,DROPtranscutaneous oxygenpressure value, andoxygen concentration (O2Hb) from
the near-infrared spectroscopic signal of the calf were recorded on both sides. Patients were instructed to report eventual
contraction-induced pain in the stimulated calf. Results are given as mean (standard deviation) or median [25th/75th
percentiles] according to distribution, and the level of statistical signiﬁcance was set at P < .05 on two-tailed tests.
Results: Lower limb inﬂow (mL/min) was 64 [48/86] vs 63 [57/81] (P > .05) before stimulation, 123 [75/156] vs 57
[44/92] (P < .01) at 60 bpm, 127 [91/207] vs 49 [43/68] (P < .01) at 75 bpm, 140 [84/200] vs 57 [45/71] (P < .01)
at 86 bpm, and 154 [86/185] vs 55 [46/94] (P < .01) at 100 bpm on the stimulated vs nonstimulated limb, respectively.
No apparent decrease or signiﬁcant leg difference was observed in DROP index or O2Hb values. None of the patients
reported contraction-induced pain in the leg.
Conclusions: Electrical stimulation of calf muscle with the Veinoplus device results in a signiﬁcant increase of arterial
inﬂow without measurable muscle ischemia or pain. Potential use of this device as an adjuvant treatment to improve
walking capacity in PAD patients remains to be evaluated. (J Vasc Surg 2013;57:714-9.)Walking limitation is one of the ﬁrst clinical complica-
tions of peripheral artery disease (PAD). Stimulating
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://dx.doi.org/10.1016/j.jvs.2012.08.117limb blood ﬂow and improving walking capacity in patients
with claudication resulting from PAD.1 Regular walking
has a beneﬁcial effect,2 but many events may preclude the
adherence of patients to this recommendation,3 including
comorbid conditions, low motivation to exercise,4 and
bad weather conditions. As an adjuvant to walking or for
patients who cannot walk, methods to induce passive
increase of limb inﬂow, such as external intermittent
compression or direct electrical muscle stimulation
(EMS), have been proposed.5-8
The fact that EMS-induced contraction can improve
blood ﬂow and decrease muscle fatigue in the ischemic
muscle has been previously suggested in animals9 and
humans.5 Among commercially available devices, the Veino-
plus (Ad Rem Technology, Paris, France) has been
proposed to increase venous outﬂow for prevention of
deep venous thrombosis.10-12 Nevertheless, direct evidence
of the tolerance of electrical-induced contractions in terms
of EMS-induced ischemia and of the amplitude of inﬂow
to the stimulated limb in PAD patients is lacking. Our
primary hypothesis was that self-selected intensity of
EMS with the Veinoplus system could induce a signiﬁcant
Fig 1. The Veinoplus device placed on a patient.
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whether direct muscle stimulation results in calf ischemia
comparable with that observed during walking has never
been assessed.
The aim of this study was to conﬁrm the tolerance and
clinical effects of electrical stimulation of muscle in patients
with PAD, that is, to determine whether self-selected EMS
with the Veinoplus apparatus is feasible and safe in PAD
patients.
METHODS
Study population. Adult patients were recruited
among the patients referred for treadmill evaluation of arte-
rial claudication at the exercise unit of the Department of
Vascular and Exercise Investigations of the University
Hospital in Angers.
Treadmill tests and exercise transcutaneous partial
pressure of oxygen. The routine exercise procedure has
been extensively described elsewhere.13-15 In brief, we
used a 10% slope and speed of 3.2 km/h for 15 minutes,
followed by an incremental phase in case of nonlimiting
claudication during the constant load phase. Exercise was
stopped on patient request. For all transcutaneous partial
pressure of oxygen (tcPO2) tests, as a routine we used
at least three transcutaneous oxygen pressure probes
(TCM400 Radiometer, Copenhagen, Denmark), one on
the chest and one on each calf. Each probe was carefully
calibrated according to the manufacturer’s recommenda-
tions. The tcPO2 values were recorded for 2 minutes in the
standing position before the treadmill was started, during
the walking period, and for 10 minutes in the standing
position after the end of the exercise test. The tcPO2 values
were automatically stored every 2 seconds by a homemade
computer program and converted to decrease from rest of
oxygen pressure (DROP) indices. The DROP index was
calculated as tcPO2 absolute changes from rest at the limb
level corrected with the absolute value of the chest tcPO2
changes, with chest changes subtracted (if increased from
rest) or added (if decreased from rest) from the changes
observed at the limb level. The DROP index has been
shown to be a reliable and accurate index for exercise-
induced regional blood ﬂow impairment at the calf and
buttock level because it is independent from absolute
starting values.13-15
Patient selection and inclusion. Patients were eligible
to the study if they had stable Fontaine stage 2 PAD for at
least 1 month, an ankle-to-brachial systolic pressure
index <0.90 on at least one side, a patent femoral artery on
the mid-third of both thighs, and no femoropopliteal
bypass. If proof of femoral patency was not available from
the patient ﬁle, it was checked by ultrasound scanning
before inclusion. The study was performed according to
the recommendation of the Declaration of Helsinki and
Register Number was NCT01592812 in the clinicaltrial.
gov database. Patients provided written informed consent
before inclusion in the study.
Investigations. Investigations were performed in the
vascular unit of the department within two to 30 days ofthe treadmill test and the stimulation performed on the
most symptomatic leg. The contralateral leg of each patient
was not stimulated and thus was used as a control. Investi-
gations were conducted in an air-conditioned room
(22C6 2C ), with the patient comfortably seated on an
armchair. A minimum period of 20 minutes in the seated
position was allowed to avoid any possible inﬂuence of
a previous walk over recordings. Thereafter, measurements
were started at rest, performed throughout the 20-minute
period of stimulation, and for 10 minutes after the end of
the stimulation.
Electrical muscle stimulation. The stimulation from
Veinoplus consists of a series of rectangular pulses of low
energy (<25 mC), low voltage (50 Vpeak), low frequency
(1-250 Hz), and maximum duration of impulse 240 ms;
intensity can be changed manually. The effective output
voltage ranges from 0.1 to 5 V root mean square (RMS),
with each intensity unit corresponding to approximately
0.1-V RMS increment. The shape of the current wave is
biphasic, leading to nearly symmetric contractions of the
muscles of the calf muscle in each leg. The device consists
of a handheld central unit that works on a battery, con-
nected to two ovoid skin adhesive electrodes. Each elec-
trode is w8 cm wide and 13 cm long. The two electrodes
of the device are positioned symmetrically on the medi-
ocentral part of the calf (Fig 1). A switch on the central unit
starts the preset EMS program, and, thereafter, the inten-
sity of stimulation can be increased (or decreased) manu-
ally. There is a wide interindividual difference in the
intensity required to reach muscle contraction as well as the
intensity to reach stimulation-induced pain. When switched
on, the device automatically delivers a stimulation of preset
incremental rate, starting with 60 bursts of stimulation per
minute (bpm) and changing to approximately 75, 86, and
100 bpm every 5 minutes. At the end of the 20 minutes of
stimulation, the device stops automatically.
For the present study, the electrodes were positioned on
the most symptomatic leg. Patients were instructed that the
intensity of stimulation would slowly increase, that they
Table I. Demographic characteristics
Gender 12 males, 3 females
Age, years 62 (12)
Height, cm 165 (8)
Weight, kg 76 (13)
Systolic arterial pressure, mm Hg 139 (15)
Diastolic arterial pressure, mm Hg 81 (11)
Lowest ankle-brachial index 0.66 (0.19)
Maximal walking distance on treadmill, m 295 [133/881]
Heart rate before the walking test, bpm 75 (14)
Heart rate at peak exercise, bpm 120 (22)
Results are given mean (standard deviation) or median [25th/75th
percentiles].
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fortable, and that thereafter the intensity of stimulation
would remain stable throughout the test. For the protocol,
after 2 minutes of rest, the Veinoplus device was started
and the intensity of stimulation was increased to reach the
optimal intensity level within 1 minute. Thereafter, electrical
stimulation could be stopped at the patient’s request in case
of ischemic pain or if the tcPO2 in the calf of the stimulated
leg (expressed as DROP index) fell by >5 mm Hg beyond
the decline observed in the same calf during the walking
test. Aminimal level of intensitywas required, corresponding
to a visible contraction of the calf muscles with comfortable
sensation. If the self-selected intensity did not result in visible
contractions, the patient was excluded from the study.
Systemic hemodynamic parameters. Systemic and
diastolic arterial pressures and heart rate were recorded every
2 minutes using Dynamap V100 (General Electric, Buc,
France), before, during, and in the 10 minutes after EMS.
Ultrasound measurements. Arterial leg inﬂow was
examined in the femoral artery with real-time gated
Doppler sonography (Sequoia 512, 8-MHz linear array
probe; Siemens SAS, Saint Denis, France). The sites to be
measured on both sides were searched on the superﬁcial
femoral artery (SFA), 3 to 15 cm from the femoral bifur-
cation in order to avoid luminal irregularities, and marked
with a permanent marker on the skin to allow repeated
measurements on both sides. The diameter of the SFA was
measured at rest on both sides before each protocol by
viewing the artery longitudinally and by placing the tracker
balleguided calipers across the intimaleluminal interphases
of the near and far walls. An average of ﬁve measurements
was used to calculate cross-sectional area. This average
value of cross-sectional area was used for calculating arterial
inﬂow. Spectral velocity data were obtained at a maximum
of 45 insonization angle with the sample volume gate
encompassing the entire lumen of the vessel and the
position of the probe marked on the skin to allow repeated
measurements at the same place. Doppler waveforms were
enveloped automatically using dedicated software for ﬂow
estimation. The mean integrated velocity (VTI) over three
cardiac cycles (three peaks systolic velocity) was measured
to calculate arterial inﬂow to the leg and performed as often
as possible, changing the side of measurement for every
three measurements of VTI. The goal was to average at
least two, optimally three, measurements on each side and
for each rate of stimulation in order to decrease measure-
ment variability. Arterial inﬂow was calculated from VTI by
the cross-sectional area of the femoral artery (L/min),
before, during, and in the 10 minutes after EMS.
The tcPO2 recording during EMS. The tcPO2 was
measured at the chest and on both calves close to the
area where they were measured for the exercise treadmill
test. Values were recorded manually every 2 minutes,
before, during, and in the 10 minutes after EMS. Results
are expressed as DROP values (mm Hg).
Near-infrared spectroscopy during EMS. Gastroc-
nemius muscle oxygenation was monitored by two pairs
of continuous-wave near-infrared spectroscopy (NIRS)probes (Oxymon Mk III; Artinis Medical Systems, Zetten,
The Netherlands). The NIRS light consisted of two
wavelengths (780 and 850 nm). Oxygen content (O2Hb)
was calculated from the age-dependent differential path-
length factors (range, 4.95-6.12). The theory, limitations,
and reliability of measurement obtained with this device
during exercise have been reported previously.16,17 The
probes consisted of one emitter and one detector (3.5 cm
one from the other) housed in a black, plastic holder afﬁxed
over the belly of the gastrocnemius lateralis. A bandage
covered and stabilized each probe holder in order to reduce
the intrusion of external light and the loss of transmitted
NIRS light from the measuring area. NIRS data were
continually acquired at 5 Hz and transferred online from
the Oxymon Mk III to a personal computer. Data were
averaged over the last 30 seconds of each seven measure-
ment periods. Results were analyzed before, during, and in
the 10 minutes after EMS.
Calculation of the number of participants. From
preliminary results we expected that the increase in arterial
inﬂow to be at least 50% at the end of muscle stimulation
compared with the contralateral limb (0%) with a variability
of 15%, and that the decrease in the DROP index during
EMS would remain smaller than the drop observed during
treadmill for the same patient. Fifteen patients were included
in order to assess the difference between the stimulated and
control limb inﬂow, with P < .01 and power >80%.
Statistical analysis. Statistical calculations were per-
formed using SPSS 16.0.1 (IBM, Bois-Colombes, France).
Mean (standard deviation) values are presented for normal
distributed variable and median [25/75 percentiles] for
non-Gaussian distributions. Statistical tests for comparison
of ﬂow values between stimulated and nonstimulated limb
were performed using Wilcoxon r-paired t-test as appro-
priate. For each test, the level of statistical signiﬁcance was
set at P < .05 on two-tailed test.
RESULTS
Characteristics of the patients are listed in Table I. All of
the patients had PAD and claudication for 1 to 20 years, and
ﬁve had undergone a lower limb revascularization. In brief,
two patients had aortic stenosis, four had infrapopliteal
lesions, ﬁve had bilateral iliofemoral lesions, and four
Table II. Decrease from rest of oxygen pressure index (median [25/75 percentiles]) during treadmill test on the most
symptomatic side (side of stimulation) and contralateral (control) side
At minute 1 At minute 2 Minimal value
Side of stimulation, mm Hg 5 [3/10] 10 [4/15] 25 [18/34]
Control side, mm Hg 3 [1/5] 5 [3/8] 14 [10/25]
Fig 2. Median arterial inﬂow with 25-75 percentiles in the
stimulated and control limb, at rest, during stimulation, and in the
10 minutes of recovery (Rec) after stimulation. Differences are
signiﬁcant between stimulated and control throughout the
stimulated period. *P < .05.
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occlusion, the femoral artery was always patent on both sides
down to the lower third of the thigh. Three patients re-
ported having type 2 diabetes, although only two were
treated with antidiabetic drugs. All but one patient received
antiplatelet agents. All but three patients were taking
cholesterol-lowering drugs. Treadmill tests reproduced
usual limb symptoms, and limitation was due to limb pain
on the treadmill except in one patient. This patient had
a self-reported maximal walking distance > 1 km at usual
walking speed. Although his symptoms were present while
he was on the treadmill, he stopped the test because of
exhaustion during the incremental phase of the treadmill
(speed 4 km/h, slope 12%). As expected, the DROP index
decreased progressively during exercise and tended to be
lower in themost symptomatic side (the one used for muscle
stimulation) than on the other side (Table II).
The stimulation was performed on the right side in eight
patients and left side in seven patients. The level of stimula-
tion reached ranged from 12 to 20 units (1.2-2 V RMS)
for all patients on the device selector, allowing for visible
calf muscle contraction in all cases. Calf EMS was well toler-
ated by all patients, and 20-minutes EMS could be
completed in all cases without contraction-induced muscle
ischemic pain, even for the seven patients with a maximal
walking time on the treadmill <5 minutes.No signiﬁcant systemic hemodynamic changes were
observed throughout the experiment, although systolic
pressure tended to decrease moderately with time as a
result of the patient being comfortably seated at rest for
30 minutes. Systolic and diastolic arterial pressures and
heart rate were 139 (10) mm Hg, 76 (11) mm Hg, and
69 (13) bpm at rest, 136 (10) mm Hg, 75 (10) mm Hg,
and 69 (14) bpm at 20 minutes of stimulation, and 134
(10) mm Hg, 76 (11) mm Hg, and 69 (12) bpm at the
end of the experiments, respectively.
Stimulation induced a signiﬁcant increase in arterial
inﬂow in the stimulated limb, whereas the inﬂow remained
stable on the control side (Fig 2). The coefﬁcient of varia-
tion of repeated measurements during the test calculated in
the nonstimulated leg was on average 18.3% (8.8%) for the
15 subjects. In the stimulated leg, we found a wide vari-
ability of inﬂow increase among subjects, ranging from
27% to >700% of resting values. The highest ﬂow value
increase was observed in a patient who had a severe stenosis
at the origin of the profunda femoris artery with multiple
but nonsigniﬁcant lesions on the SFA on the stimulated
side. The lowest value was observed in a patient with distal
occlusion of the SFA.
No relationship was found between the intensities of
stimulation and ﬂow (r¼ 0.20; P > .05). No difference in
ﬂow increase was found in perspective of treatments. Flow
increase was 192% among the six patients who did not
receive a vasodilating drug (nitrate, angiotensin-converting
enzyme inhibitor, naftidrofuril, angiotensin-receptor antag-
onists) vs 181% in patients who did receive a treatment.
Although stimulation signiﬁcantly increased arterial
inﬂow, there was no apparent decrease in tcPO2 (DROP
index) during and in the 10 minutes after stimulation
(Fig 3). Speciﬁcally, the lowest value observed during all
sessions of 20 minutes of EMS was e10 mm Hg. This
lowest value was found in a patient whose value after 6-
minute walk on the treadmill (w300 m) was e25 mm
Hg. Consistently, no signiﬁcant difference was found on
the NIRS signal between the right and left legs during
and after EMS (Fig 4).
DISCUSSION
Muscle contraction induced by EMS seems to be well
tolerated by PAD patients with claudication. EMS induced
no pain due to the stimulation itself and no ischemic pain
even though the total duration of EMS by far exceeded
the duration of treadmill tests, limited by walking-
induced pain in the same patients. This observation likely
is a result of the moderate intensity of muscle contraction
Fig 3. Median decrease from rest of the transcutaneous oxygen
pressure (tcPO2) decrease from rest of oxygen pressure (DROP)
index with 25-75 percentiles observed during and in the
10 minutes of recovery (Rec) after stimulation. The minimum
values observed on treadmill are shown as references.
Fig 4. Near-infrared spectroscopy oxygen content (HbO2) of the
gastrocnemius lateralis muscle observed before, during, and in the
10 minutes of recovery (Rec) after stimulation.
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tent with the absence of signiﬁcant O2Hb or tcPO2 DROP
index decrease on the stimulated leg compared with the
nonstimulated leg. The NIRS changes during EMS were
very small and extremely limited compared with the
changes reported in the literature during walking tests.18
Furthermore, tcPO2 changes during EMS were much
smaller than the changes observed during walking tests in
the same patients. Consistently, the inﬂow increase found
in this study remains moderate compared with the esti-
mated limb ﬂow increase observed during walking in
healthy subjects. Indeed, blood ﬂow to the anterior tibial
compartment increased three- to fourfold during muscle
contraction in healthy humans19 and is dependent of age
and exercise intensity.20 The inﬂow values observed in
the present study for the SFA were quite low comparedwith values in some previous reports.8,20-22 It is likely
that calculating limb inﬂow from the sole SFA underesti-
mated the total leg inﬂow increase due to collateral circula-
tion through the profunda femoris artery at the thigh level.
The distribution of ﬂow between the SFA and the profunda
femoris artery is highly variable, and inﬂow in the SFA is
decreased in the presence of lesions in this artery and is
increased after angioplasty.21,22 We believe that the inﬂow
differences we observed likely resulted from the distribu-
tion of vessel lesions between the profunda femoris and
the SFA. In the patient who showed the highest increase
in inﬂow, we assume that all of the inﬂow increase was
driven by the SFA, whereas in all other patients, the vari-
able percentage of leg inﬂow was derived toward the pro-
funda femoris artery. It is clear that total limb ﬂow is,
roughly, the sum of the inﬂow through the SFA and the
profunda femoris arteries. The leg inﬂow that we measured
likely was underestimated compared with the total ﬂow of
the limb. Thermodilution and xenon scintigraphy are inva-
sive and not easily performed with patients in the seated
position, and plethysmography results are inﬂuenced by
the position of the limb from the heart.23 It was not
possible to measure both arteries on both sides with ultra-
sound in our experimental conditions. It could be sug-
gested that measurement of arterial inﬂow at the level of
the common femoral or popliteal arteries would have
been preferable, but these arteries are difﬁcult to access
with patients in the seated position. Another point is that
the absence of repeated diameter measurements may have
interfered with our results, which could have underesti-
mated arterial inﬂow changes.
There are other limitations to the present study. First,
because the treadmill tests and EMS experiments were
not performed in the same unit of the department, we
could not record NIRS changes during exercise. Second,
it is likely that greater changes could be attained if the
intensity of stimulation, and the resulting force of muscle
contraction, was increased. Nevertheless, the aim was to
test the effect of tolerable (comfortable) use of the device
in the setting of repetitive use “at home” without medical
supervision, which we aim to study in the future. The
intensity required to reach stimulation-induced muscle
contraction was variable among subjects. Reasons for these
differences (eg, electrode position, subcutaneous fat thick-
ness, water content of the tissues) remain unknown. Third,
the population studied showed relatively moderate severe
claudication. This ﬁnding probably relies on the fact that
we studied only patients with a patent SFA (at least of
the ﬁrst third) on both sides to allow ultrasound measure-
ments. Clinical tolerance of EMS in patients with severe
claudication or critical limb ischemia should be studied in
another population. Finally, it could be suggested that
the variability of ﬂow increase resulted from the fact that
arterial lesions were either proximal (aortoiliac) or distal.
We believe this was not the case, but future experiments
might be required to determine a difference in leg inﬂow
between patients with suprainguinal and those with infra-
geniculate disease.
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view of potential use of EMS as an adjuvant treatment in
PAD patients with claudication but remain to be evaluated.
The absence of signiﬁcant muscle ischemia on tissue satura-
tion and DROP index is of major interest to prevent pain
and for safety reasons if the device were to be used by
the patient at home without medical supervision. Never-
theless, although the absence of pain and measurable
ischemia during EMS may be beneﬁcial from a compliance
standpoint, it cannot be excluded that the oxidative stress
of ischemia is as important as inducing increased arterial
inﬂow in improving walking capacity, in which case, electri-
cal stimulation would be less beneﬁcial. We assume this is
not the case because low-intensity treadmill walking exer-
cise seems to be effective in improving maximum walking
distance, even within a 6-week period for patients with
intermittent claudication due to PAD.24
CONCLUSIONS
All study patients were able to self-select a level of inten-
sity from the Veinoplus device that resulted in visible muscle
contraction. The EMS of calf muscle resulted in a signiﬁcant
increase of arterial inﬂow in the SFA, without inducing
ischemic pain in patients with PAD and a patent SFA. The
decrease in tcPO2 DROP index during and in the
10 minutes after EMS was extremely limited compared
with the DROP index observed in the same leg and in the
same patients during a treadmill walking test. Similarly, the
NIRS O2Hb values remained almost unchanged on the
stimulated gastrocnemiusmuscle, suggesting that nomeasur-
able calf muscle ischemia occurred during or after EMS.
AD Rem Technology kindly provided the EMS device.
We are indebted to Marie Gernigon, Yoanna Onillon, and
the team from the Centre de Recherche Clinique of the
University Hospital for technical help.
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